How does stigma impact treatment in tuberculosis? Has the COVID-19 pandemic enabled high income countries to commiserate with lower middle income countries who have high infectious disease burden? Are antimicrobials impacting the way some countries treat tuberculosis? Dr Paul Mason explores these questions while addressing other ethical issues in tuberculosis.
Dr Paul Mason is an anthropologist who has conducted community-based research in Indonesia, India and Brazil, behaviour change research in Vietnam and Brazil, and laboratory research in Australia and France. Paul’s research interests include a deep fascination with biological and cultural diversity, social and multispecies justice, and interdisciplinary and cross-cultural efforts towards establishing long-lasting planetary health.